Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Bone mineral density in patients with alopecia areata treated with long-term intralesional corticosteroids.

Samrao A, Fu JM, Harris ST, Price VH.

J Drugs Dermatol. 2013 Feb;12(2):e36-40.

PMID:
23377403
2.

Dermoscopic evaluation of therapeutic response to an intralesional corticosteroid in the treatment of alopecia areata.

Ganjoo S, Thappa DM.

Indian J Dermatol Venereol Leprol. 2013 May-Jun;79(3):408-17. doi: 10.4103/0378-6323.110767.

3.

Osteopenia in patients with glomerular diseases requiring long-term corticosteroid therapy.

de Deus RB, Ferreira AC, Kirsztajn GM, Heilberg IP.

Nephron Clin Pract. 2003;94(3):c69-74.

PMID:
12902633
4.

The pattern and profile of alopecia areata in Singapore--a study of 219 Asians.

Tan E, Tay YK, Goh CL, Chin Giam Y.

Int J Dermatol. 2002 Nov;41(11):748-53.

PMID:
12452996
5.

Changes in bone mineral density in postmenopausal women treated with epidural steroid injections for lower back pain.

Kang SS, Hwang BM, Son H, Cheong IY, Lee SJ, Chung TY.

Pain Physician. 2012 May-Jun;15(3):229-36.

6.

Treatment of severe alopecia areata with intralesional steroid injections.

Chang KH, Rojhirunsakool S, Goldberg LJ.

J Drugs Dermatol. 2009 Oct;8(10):909-12.

PMID:
19852119
7.

Intralesional corticosteroid therapy in hemangiomas: clinical outcome in 160 cases.

Chantharatanapiboon W.

J Med Assoc Thai. 2008 Oct;91 Suppl 3:S90-6.

PMID:
19253502
8.

Bone mineral density changes in women with systemic lupus erythematosus.

Boyanov M, Robeva R, Popivanov P.

Clin Rheumatol. 2003 Oct;22(4-5):318-23.

PMID:
14579164
9.

Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements.

Gulati S, Sharma RK, Gulati K, Singh U, Srivastava A.

Nephrol Dial Transplant. 2005 Aug;20(8):1598-603. Epub 2005 Jun 14.

PMID:
15956073
10.

Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus.

Compeyrot-Lacassagne S, Tyrrell PN, Atenafu E, Doria AS, Stephens D, Gilday D, Silverman ED.

Arthritis Rheum. 2007 Jun;56(6):1966-73.

11.

Low bone mineral density in adult patients with moderate to severe atopic dermatitis.

Haeck IM, Hamdy NA, Timmer-de Mik L, Lentjes EG, Verhaar HJ, Knol MJ, de Bruin-Weller MS, Bruijnzeel-Koomen CA.

Br J Dermatol. 2009 Dec;161(6):1248-54. doi: 10.1111/j.1365-2133.2009.09327.x. Epub 2009 Jun 4.

PMID:
19673879
12.

Total calcium intake is associated with cortical bone mineral density in a cohort of postmenopausal women not taking estrogen.

Suzuki Y, Whiting SJ, Davison KS, Chilibeck PD.

J Nutr Health Aging. 2003;7(5):296-9.

PMID:
12917743
13.

No association between inhaled corticosteroids and whole body DXA in postmenopausal women.

Elmståhl S, Ekström H, Johnell O, Gerhardsson de Verdier M, Norjavaara E.

Pharmacoepidemiol Drug Saf. 2006 Jul;15(7):527-35.

PMID:
16715539
14.

Intralesional Triamcinolone Acetonide Versus Topical Betamethasone Valearate in the Management of Localized Alopecia Areata.

Devi M, Rashid A, Ghafoor R.

J Coll Physicians Surg Pak. 2015 Dec;25(12):860-2. doi: 12.2015/JCPSP.860862.

PMID:
26691357
15.

Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluoride.

Abitbol V, Mary JY, Roux C, Soulé JC, Belaiche J, Dupas JL, Gendre JP, Lerebours E, Chaussade S; Groupe D'etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID)..

Aliment Pharmacol Ther. 2002 May;16(5):919-27.

16.

Are children with idiopathic nephrotic syndrome at risk for metabolic bone disease?

Gulati S, Godbole M, Singh U, Gulati K, Srivastava A.

Am J Kidney Dis. 2003 Jun;41(6):1163-9.

PMID:
12776267
17.

Long-term bone loss in kidney transplant recipients: a cross-sectional and longitudinal study.

Pichette V, Bonnardeaux A, Prudhomme L, Gagné M, Cardinal J, Ouimet D.

Am J Kidney Dis. 1996 Jul;28(1):105-14.

PMID:
8712204
18.

[Bone mineral density disminution post Roux-Y bypass surgery].

Papapietro K, Massardo T, Riffo A, Díaz E, Araya AV, Adjemian D, Montesinos G, Castro G.

Nutr Hosp. 2013 May-Jun;28(3):631-6. doi: 10.3305/nh.2013.28.3.6400. Spanish.

19.

Bone mineral density, fracture, and vitamin D in adolescents and young women using depot medroxyprogesterone acetate.

Pitts SA, Feldman HA, Dorale A, Gordon CM.

J Pediatr Adolesc Gynecol. 2012 Feb;25(1):23-6. doi: 10.1016/j.jpag.2011.07.014. Epub 2011 Nov 12.

PMID:
22078997
20.

Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis.

Bernstein CN, Seeger LL, Sayre JW, Anton PA, Artinian L, Shanahan F.

J Bone Miner Res. 1995 Feb;10(2):250-6.

PMID:
7754804

Supplemental Content

Support Center